Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancer

Trial Profile

Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancer

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2018

At a glance

  • Drugs Carperitide (Primary)
  • Indications Acute heart failure
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Jan 2018 Status changed from recruiting to active, no longer recruiting.
    • 28 Jan 2018 Planned number of patients changed from 6 to 7.
    • 28 Jul 2017 Planned number of patients changed from 5 to 6.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top